title: Development of a Stability-Indicating Stereoselective Method for Quantification of the Enantiomer in the Drug Substance and Pharmaceutical Dosage Form of Rosuvastatin Calcium by an Enhanced Approach.
abstract: A novel, simple, precise, and stability-indicating stereoselective method was developed and validated for the accurate quantification of the enantiomer in the drug substance and pharmaceutical dosage forms of Rosuvastatin Calcium. The method is capable of quantifying the enantiomer in the presence of other related substances. The chromatographic separation was achieved with an immobilized cellulose stationary phase (Chiralpak IB) 250 mm x 4.6 mm x 5.0 μm particle size column with a mobile phase containing a mixture of n-hexane, dichloromethane, 2-propanol, and trifluoroacetic acid in the ratio 82:10:8:0.2 (v/v/v/v). The eluted compounds were monitored at 243 nm and the run time was 18 min. Multivariate analysis and statistical tools were used to develop this highly robust method in a short span of time. The stability-indicating power of the method was established by subjecting Rosuvastatin Calcium to the stress conditions (forced degradation) of acid, base, oxidative, thermal, humidity, and photolytic degradation. Major degradation products were identified and found to be well-resolved from the enantiomer peak, proving the stability-indicating power of the method. The developed method was validated as per International Conference on Harmonization (ICH) guidelines with respect to specificity, limit of detection and limit of quantification, precision, linearity, accuracy, and robustness. The method exhibited consistent, high-quality recoveries (100 ± 10%) with a high precision for the enantiomer. Linear regression analysis revealed an excellent correlation between the peak responses and concentrations (r(2) value of 0.9977) for the enantiomer. The method is sensitive enough to quantify the enantiomer above 0.04% and detect the enantiomer above 0.015% in Rosuvastatin Calcium. The stability tests were also performed on the drug substances as per ICH norms.
authors.affiliation: Department of Chemistry, Sri Krishnadevaraya University, Anantapur 515001, A.P, India.
authors.forename: Gangireddy
authors.initials: G
authors.lastname: Rajendra Reddy
authors.affiliation: Department of Chemistry, Sri Krishnadevaraya University, Anantapur 515001, A.P, India.
authors.forename: Papammagari
authors.initials: P
authors.lastname: Ravindra Reddy
authors.affiliation: Department of Chemistry, Sri Krishnadevaraya University, Anantapur 515001, A.P, India.
authors.forename: Polisetty
authors.initials: P
authors.lastname: Siva Jyothi
keywords: Forced degradation; ICH guidelines; Immobilized cellulose stationary phase (Chiralpak IB); Stability-indicating method; Stereoselective method
references.citation: Am J Cardiol. 2003 Jul 15;92(2):152-60
references.pmid: 12860216
references.citation: Expert Opin Drug Metab Toxicol. 2008 Mar;4(3):287-304
references.pmid: 18363544
references.citation: Pharmacol Rev. 2012 Jan;64(1):102-46
references.pmid: 22106090
references.citation: Cardiovasc Drugs Ther. 2008 Aug;22(4):321-38
references.pmid: 18553127
references.citation: J Cardiol. 2012 Nov;60(5):383-8
references.pmid: 22884684
references.citation: Sci Pharm. 2013 Aug 12;81(4):1043-56
references.pmid: 24482772
references.citation: J Chromatogr Sci. 2011;49(6):439-46
references.pmid: 21682993
references.citation: Br J Clin Pharmacol. 2004 Mar;57(3):279-86
references.pmid: 14998424
references.citation: Br J Clin Pharmacol. 2002 Nov;54(5):472-7
references.pmid: 12445025
references.citation: Comb Chem High Throughput Screen. 2012 May 1;15(4):339-46
references.pmid: 22263889
references.citation: Fed Regist. 2012 Nov 20;77(224):69634-5
references.pmid: 23227566
references.citation: Sci Pharm. 2012 Jun;80(2):393-406
references.pmid: 22896825